HIM
BIO icon

Hermes Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Hermes Investment Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$56.2M Buy
194,945
+2,634
+1% +$727K 0.75% 43
2018
Q1 		$48.1M Buy
192,311
+654
+0.3% +$167K 0.7% 49
2017
Q4 		$45.7M Sell
191,657
-2,439
-1% -$591K 0.66% 54
2017
Q3 		$43.1M Sell
194,096
-6,744
-3% -$1.52M 0.65% 54
2017
Q2 		$45.5M Sell
200,840
-97,533
-33% -$21.3M 0.74% 45
2017
Q1 		$59.5M Sell
298,373
-13,339
-4% -$2.57M 0.96% 32
2016
Q4 		$56.8M Buy
311,712
+43,280
+16% +$7.38M 0.97% 34
2016
Q3 		$44M Buy
268,432
+18,814
+8% +$2.86M 0.75% 47
2016
Q2 		$35.7M Buy
249,618
+65,128
+35% +$9.29M 0.72% 52
2016
Q1 		$25.7M Sell
184,490
-30,596
-14% -$4.02M 0.54% 76
2015
Q4 		$29.8M Buy
215,086
+12,295
+6% +$1.7M 0.67% 60
2015
Q3 		$27.2M Sell
202,791
-1,694
-0.8% -$244K 0.7% 61
2015
Q2 		$30.8M Buy
204,485
+3,944
+2% +$564K 0.69% 61
2015
Q1 		$27.1M Buy
200,541
+24,913
+14% +$3.09M 0.63% 73
2014
Q4 		$21.2M Sell
175,628
-42,753
-20% -$4.92M 0.55% 82
2014
Q3 		$24.8M Buy
218,381
+3,825
+2% +$453K 0.64% 73
2014
Q2 		$25.7M Sell
214,556
-35,858
-14% -$4.38M 0.71% 63
2014
Q1 		$32.1M Buy
+250,414
New +$32.1M 1.01% 48

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hermes Investment Management's BIO Position: Q2 2018 in Review

Hermes Investment Management increased its Bio-Rad Laboratories Class A (BIO) stake by 1.4% in Q2 2018, buying an estimated $727K and bringing the position to 194,945 shares worth $56.2M. The position accounts for 0.75% of the portfolio, ranked #43.

Hermes Investment Management first reported a position in BIO in Q1 2014 and has held it in 18 quarters since. The position peaked at $59.5M in Q1 2017. 326 funds tracked by Wall St. Rank hold BIO as of Q2 2018.

  • Hermes Investment Management held 194,945 shares of Bio-Rad Laboratories Class A worth $56.2M as of Q2 2018.
  • Hermes Investment Management bought 2,634 Bio-Rad Laboratories Class A shares in Q2 2018, an estimated $727K.
  • Bio-Rad Laboratories Class A made up 0.75% of Hermes Investment Management's portfolio in Q2 2018, its #43 holding.
  • Hermes Investment Management first reported a position in Bio-Rad Laboratories Class A in Q1 2014 and has held it in 18 quarters since.
  • Hermes Investment Management's Bio-Rad Laboratories Class A position peaked at $59.5M in Q1 2017.
  • 326 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2018.

Based on Hermes Investment Management's 13F filing for Q2 2018, filed 24 Jul 2018.